SA biotech pursuing deal to access $5B China market

FEBRUARY 8, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal “China represents a $5 billion market for CyPath© Lung. An estimated 780,000 people will be diagnosed annually in China with lung...

SA Biotech Nearing Launch of Breakthrough Cancer Test

AUGUST 11, 2020 As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal A local pathology practice has initiated a validation study of San Antonio-based bioAffinity Technologies’ CyPath Lung early...